G1 Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in G1 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including G1 Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in G1 Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $69k | 23k | 3.05 |
| 2023-09-30 | $31k | 21k | 1.44 |
| 2023-06-30 | $76k | 31k | 2.49 |
| 2022-12-31 | $138k | 26k | 5.43 |
| 2022-09-30 | $685k | 54k | 12.61 |
| 2022-06-30 | $157k | 32k | 4.94 |
| 2022-03-31 | $343k | 45k | 7.60 |
| 2021-12-31 | $586k | 58k | 10.20 |
| 2021-09-30 | $1.5M | 106k | 14.29 |
| 2021-06-30 | $2.8M | 97k | 28.57 |
| 2021-03-31 | $1.9M | 79k | 24.06 |
| 2020-12-31 | $759k | 42k | 18.00 |
| 2020-09-30 | $349k | 30k | 11.55 |
| 2020-06-30 | $671k | 28k | 24.26 |
| 2020-03-31 | $216k | 20k | 11.02 |
| 2019-12-31 | $502k | 19k | 26.42 |
| 2019-09-30 | $455k | 20k | 22.80 |
| 2019-06-30 | $418k | 14k | 30.68 |
| 2019-03-31 | $251k | 15k | 16.60 |
| 2018-12-31 | $290k | 15k | 19.16 |
| 2018-09-30 | $539k | 10k | 52.28 |
| 2018-06-30 | $419k | 9.6k | 43.49 |
| 2018-03-31 | $206k | 5.6k | 37.09 |
| 2017-12-31 | $92k | 4.7k | 19.76 |